Shwetha Anand, MD
Endocrinology · San Leandro
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 4 carriers
- Office
- 1
- Since medical school
- 26 years
- Graduated 2000
Offices
1 location · Epic Care · 54 clinicians in this group
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Eden Medical Center · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
10 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anand’s office at (510) 351-1193 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A131831 · Current
Licensed to practise in California · since 2014 · expires 2028-03-31 · Bangalore University Kempegowda Institute of Medical Science.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Eden Medical CenterCastro Valley, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.122, Oct 2024 – Sep 2025
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Eden Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.122 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.89) · 819 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.46 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 137.41 (92.94 to 181.88) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 38 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.1 · 207 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 355 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,714 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 4,697 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.1 to 0.5) · 4,676 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 860 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0 to 3.24) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.75 (1.17 to 4.32) · 818 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.76 (0 to 15.78) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.08 to 10.1) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.64 (0.16 to 3.12) · 233 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,132 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 60 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.431 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.292 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.307 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.61 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 258 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.6 · 225 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.4 · 367 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 390 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.6 to 17.4) · 68 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 205 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$195,236
Medicare paid this office $195,236 for 613 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Telephone medical discussion with physician, 21-30 minutes | 295 | $55,633 | $113 |
| Return visit (30+ min) | 219 | $36,977 | $112 |
| Long return visit (40+ min) | 136 | $34,655 | $170 |
| New patient visit (60+ min) | 100 | $16,503 | $165 |
| Injection, denosumab, 1 mg | 11 | $15,152 | None |
See all 16 services
| Telephone medical discussion with physician, 21-30 minutes | 295 | $55,633 | $113 |
| Return visit (30+ min) | 219 | $36,977 | $112 |
| Long return visit (40+ min) | 136 | $34,655 | $170 |
| New patient visit (60+ min) | 100 | $16,503 | $165 |
| Injection, denosumab, 1 mg | 11 | $15,152 | None |
| New patient visit (45+ min) | 105 | $14,278 | $136 |
| Telephone medical discussion with physician, 11-20 minutes | 101 | $10,941 | $84 |
| Short return visit (20+ min) | 27 | $2,447 | $82 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 46 | $2,369 | $31 |
| Hemoglobin a1c level | 112 | $1,380 | $10 |
| Insertion of needle into vein for collection of blood sample | 107 | $1,367 | $9 |
| Telephone medical discussion with physician, 5-10 minutes | 15 | $985 | $58 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 31 | $259 | $8 |
| Injection of drug or substance under skin or into muscle | 11 | $178 | $15 |
| Blood glucose (sugar) test performed by hand-held instrument | 24 | $87 | $3 |
| Blood glucose (sugar) measurement using reagent strip | 12 | $59 | $5 |
Who their Medicare patients are
613 Original Medicare patients in 2024. Average age 70 · Under 65 19% · 85 and older 8% · Women 72% · Also on Medicaid 80% · Health risk score 1.53. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 64% · Chronic kidney disease 34% · Coronary heart disease 18% · Depression 17% · Heart failure 15% · Cancer 11% · COPD 11% · Atrial fibrillation 11% · Stroke 10% · Dementia 5%.
The office billed $760,333, Medicare allowed $271,212 and paid $195,236; for 2,883 services of 29 kinds; $15,391 of it was for drugs given in the office and $179,845 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 613 | 2,883 | 70 | 1.53 | $760,333 | $195,236 |
| 2023 | 447 | 1,605 | 70 | 1.40 | $380,748 | $98,524 |
| 2022 | 440 | 1,455 | 70 | 1.45 | $405,303 | $82,433 |
| 2021 | 423 | 1,374 | 69 | 1.57 | $413,797 | $92,948 |
| 2020 | 414 | 1,317 | 68 | 1.63 | $235,788 | $82,853 |
| 2019 | 371 | 2,036 | 68 | 1.72 | $398,494 | $96,188 |
| 2018 | 284 | 1,274 | 67 | 1.94 | $325,509 | $77,772 |
| 2017 | 293 | 1,200 | 69 | 1.82 | $288,679 | $71,783 |
| 2016 | 252 | 1,199 | 71 | 2.13 | $285,318 | $73,223 |
| 2015 | 265 | 788 | 75 | 1.88 | $232,128 | $59,635 |
| 2014 | 59 | 115 | 75 | 1.59 | $29,296 | $7,569 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Telephone medical discussion with physician, 21-30 minutes | 238 | $27,867 | $74 |
| Return visit (30+ min) | 157 | $23,626 | $110 |
| Long return visit (40+ min) | 80 | $15,989 | $147 |
| New patient visit (60+ min) | 50 | $8,496 | $170 |
| New patient visit (45+ min) | 42 | $5,373 | $128 |
| Telephone medical discussion with physician, 11-20 minutes | 74 | $4,261 | $51 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 27 | $1,262 | $32 |
| Hemoglobin a1c level | 88 | $1,142 | $10 |
| Short return visit (20+ min) | 14 | $1,088 | $78 |
| Insertion of needle into vein for collection of blood sample | 67 | $764 | $8 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 23 | $228 | $8 |
| Blood glucose (sugar) measurement using reagent strip | 29 | $173 | $5 |
2022: 9 services
| Telephone medical discussion with physician, 21-30 minutes | 280 | $39,254 | $79 |
| Return visit (30+ min) | 96 | $13,515 | $106 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 51 | $7,899 | $155 |
| Long return visit (40+ min) | 26 | $5,590 | $169 |
| Telephone medical discussion with physician, 11-20 minutes | 78 | $4,992 | $50 |
| New patient visit (60+ min) | 23 | $4,411 | $192 |
| New patient visit (45+ min) | 15 | $1,551 | $103 |
| Hemoglobin a1c level | 36 | $434 | $9 |
| Insertion of needle into vein for collection of blood sample | 78 | $315 | $3 |
2021: 6 services
| Telephone medical discussion with physician, 21-30 minutes | 355 | $71,630 | $102 |
| Return visit (30+ min) | 63 | $8,274 | $107 |
| Telephone medical discussion with physician, 11-20 minutes | 101 | $8,013 | $66 |
| Hemoglobin a1c level | 22 | $252 | $10 |
| Blood test, comprehensive group of blood chemicals | 16 | $169 | $11 |
| Insertion of needle into vein for collection of blood sample | 36 | $117 | $3 |
2020: 9 services
| Telephone medical discussion with physician, 21-30 minutes | 305 | $47,574 | $97 |
| Return visit (30+ min) | 202 | $18,379 | $69 |
| New patient visit (45+ min) | 55 | $6,082 | $111 |
| Telephone medical discussion with physician, 11-20 minutes | 58 | $4,610 | $71 |
| Short return visit (20+ min) | 43 | $2,389 | $54 |
| New patient visit (30+ min) | 11 | $1,009 | $92 |
| Hemoglobin a1c level | 84 | $813 | $9 |
| Blood glucose (sugar) measurement using reagent strip | 95 | $520 | $5 |
| Insertion of needle into vein for collection of blood sample | 17 | $53 | $3 |
2019: 7 services
| Return visit (30+ min) | 310 | $66,826 | $92 |
| New patient visit (45+ min) | 103 | $13,805 | $134 |
| Short return visit (20+ min) | 45 | $3,521 | $61 |
| Hemoglobin a1c level | 184 | $3,184 | $11 |
| New patient visit (30+ min) | 13 | $1,180 | $91 |
| Blood glucose (sugar) measurement using reagent strip | 133 | $904 | $5 |
| Insertion of needle into vein for collection of blood sample | 103 | $476 | $3 |
2018: 5 services
| Return visit (30+ min) | 223 | $53,985 | $92 |
| New patient visit (45+ min) | 78 | $10,256 | $131 |
| Short return visit (20+ min) | 67 | $4,870 | $54 |
| Hemoglobin a1c level | 151 | $2,975 | $12 |
| Insertion of needle into vein for collection of blood sample | 81 | $335 | $3 |
2017: 15 services
| Return visit (30+ min) | 186 | $35,895 | $86 |
| New patient visit (45+ min) | 84 | $11,081 | $132 |
| Short return visit (20+ min) | 99 | $8,114 | $62 |
| Long return visit (40+ min) | 22 | $2,609 | $119 |
| Hemoglobin a1c level | 98 | $1,670 | $13 |
| New patient visit (30+ min) | 16 | $1,426 | $89 |
| Test for hearing various pitches using earphone | 14 | $438 | $31 |
| Vitamin d-3 level | 11 | $438 | $40 |
| Blood test, lipids (cholesterol and triglycerides) | 22 | $373 | $15 |
| Hemoglobin a1c level, by device for home use | 27 | $365 | $13 |
| Blood test, comprehensive group of blood chemicals | 27 | $364 | $12 |
| Blood test, thyroid stimulating hormone (tsh) | 12 | $271 | $23 |
| Insertion of needle into vein for collection of blood sample | 47 | $191 | $3 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 11 | $115 | $10 |
| Blood test, clotting time | 12 | $95 | $5 |
2016: 19 services
| Return visit (30+ min) | 135 | $24,619 | $87 |
| Short return visit (20+ min) | 143 | $15,587 | $54 |
| New patient visit (45+ min) | 61 | $7,705 | $126 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,195 | $162 |
| Long return visit (40+ min) | 25 | $3,197 | $123 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 14 | $2,152 | $154 |
| Vitamin d-3 level | 20 | $948 | $40 |
| Blood test, comprehensive group of blood chemicals | 36 | $660 | $13 |
| Blood test, thyroid stimulating hormone (tsh) | 25 | $650 | $22 |
| Administration of influenza virus vaccine | 17 | $509 | $30 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 12 | $406 | $34 |
| Hemoglobin a1c level | 28 | $389 | $13 |
| Hemoglobin a1c level, by device for home use | 25 | $337 | $13 |
| Administration of pneumococcal vaccine | 11 | $329 | $30 |
| Blood test, lipids (cholesterol and triglycerides) | 19 | $328 | $14 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 25 | $301 | $10 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 18 | $285 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $214 | $13 |
| Insertion of needle into vein for collection of blood sample | 47 | $209 | $3 |
2015: 6 services
| Return visit (30+ min) | 129 | $24,803 | $88 |
| Short return visit (20+ min) | 169 | $18,637 | $61 |
| New patient visit (45+ min) | 41 | $5,123 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,824 | $174 |
| Long return visit (40+ min) | 21 | $2,583 | $123 |
| Insertion of needle into vein for collection of blood sample | 18 | $53 | $3 |
2014: 2 services
| Return visit (30+ min) | 32 | $4,215 | $96 |
| Short return visit (20+ min) | 33 | $2,254 | $61 |
Medicaid work
$96,557 in 2024
Medicaid paid $96,557 for 2,970 billed services this clinician did in 2024, up to 150 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,367 | $43,865 |
| Long return visit (40+ min) | 450 | $17,358 |
| New patient visit (60+ min) | 341 | $14,941 |
| New patient visit (45+ min) | 301 | $12,840 |
| Short return visit (20+ min) | 233 | $4,966 |
| Hemoglobin A1C level | 189 | $1,950 |
| Ambulatory continuous glucose monitoring of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; analysis, interpretation and report | 73 | $637 |
| Short return visit | 16 | $0 |
| 2024 | 2,970 | 8 | 150 | $96,557 |
| 2023 | 1,781 | 6 | 117 | $26,325 |
| 2022 | 1,258 | 5 | 138 | $16,835 |
| 2021 | 1,551 | 5 | 140 | $27,459 |
| 2020 | 1,944 | 6 | 128 | $50,042 |
| 2019 | 1,823 | 5 | 113 | $36,515 |
| 2018 | 1,321 | 4 | 96 | $29,009 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 996 | $13,340 |
| New patient visit (60+ min) | 189 | $4,706 |
| Long return visit (40+ min) | 247 | $3,945 |
| New patient visit (45+ min) | 121 | $2,229 |
| Hemoglobin A1C level | 127 | $1,260 |
| Short return visit (20+ min) | 101 | $845 |
2022
| Return visit (30+ min) | 1,068 | $12,969 |
| New patient visit (60+ min) | 82 | $2,802 |
| Long return visit (40+ min) | 54 | $858 |
| Short return visit (20+ min) | 42 | $129 |
| Hemoglobin A1C level | 12 | $77 |
2021
| Return visit (30+ min) | 1,172 | $21,290 |
| New patient visit (45+ min) | 153 | $3,313 |
| Short return visit (20+ min) | 177 | $1,753 |
| New patient visit (60+ min) | 37 | $1,103 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 21-30 minutes of medical discussion | 12 | $0 |
2020
| Return visit (30+ min) | 1,186 | $32,242 |
| New patient visit (45+ min) | 295 | $12,311 |
| Short return visit (20+ min) | 219 | $4,344 |
| New patient visit (30+ min) | 55 | $945 |
| Glucose; blood, reagent strip | 118 | $163 |
| Hemoglobin A1C level | 71 | $35 |
2019
| Return visit (30+ min) | 1,041 | $27,270 |
| New patient visit (45+ min) | 281 | $8,592 |
| Short return visit (20+ min) | 48 | $391 |
| Glucose; blood, reagent strip | 190 | $179 |
| Hemoglobin A1C level | 263 | $83 |
2018
| Return visit (30+ min) | 782 | $20,256 |
| New patient visit (45+ min) | 216 | $7,714 |
| Short return visit (20+ min) | 102 | $970 |
| Hemoglobin A1C level | 221 | $69 |
Drugs they prescribed that Part D paid
$2,638,821
Pharmacies billed $2,638,821 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,011) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,489 generic and 2,192 brand-name prescriptions · $2,638,821 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 453 | $724,817 | $1,600 |
| Jardiance | 243 | $340,555 | $1,401 |
| Trulicity | 142 | $283,757 | $1,998 |
| Farxiga | 119 | $149,172 | $1,254 |
| Teriparatide | 50 | $121,591 | $2,432 |
See all 58 drugs
| Ozempic | 453 | $724,817 | $1,600 |
| Jardiance | 243 | $340,555 | $1,401 |
| Trulicity | 142 | $283,757 | $1,998 |
| Farxiga | 119 | $149,172 | $1,254 |
| Teriparatide | 50 | $121,591 | $2,432 |
| Forteo | 21 | $112,183 | $5,342 |
| Mounjaro | 63 | $109,321 | $1,735 |
| Tresiba Flextouch U-100 | 154 | $106,840 | $694 |
| Fiasp Flextouch | 67 | $96,591 | $1,442 |
| Januvia | 72 | $81,696 | $1,135 |
| Tresiba Flextouch U-200 | 55 | $67,129 | $1,221 |
| Toujeo Solostar | 84 | $51,706 | $616 |
| Tymlos | 11 | $49,297 | $4,482 |
| Basaglar Kwikpen U-100 | 63 | $30,674 | $487 |
| Rybelsus | 12 | $29,373 | $2,448 |
| Humalog Kwikpen U-100 | 54 | $24,677 | $457 |
| Nano 2nd Gen Pen Needle | 200 | $21,881 | $109 |
| Dapagliflozin | 28 | $20,573 | $735 |
| Toujeo Max Solostar | 25 | $16,317 | $653 |
| Tradjenta | 14 | $14,691 | $1,049 |
| Insulin Lispro Kwikpen U-100 | 58 | $13,701 | $236 |
| Novolog Flexpen | 53 | $11,281 | $213 |
| Cinacalcet | 16 | $10,291 | $643 |
| Vascepa | 16 | $7,866 | $492 |
| Novolog Mix 70-30 Flexpen | 23 | $6,548 | $285 |
| Lantus Solostar | 53 | $5,434 | $103 |
| Humalog | 20 | $3,810 | $191 |
| Synthroid | 29 | $3,131 | $108 |
| Admelog Solostar | 11 | $3,105 | $282 |
| Insulin Aspart Flexpen | 16 | $2,974 | $186 |
| Ultra-Fine Short Pen Needle | 22 | $2,965 | $135 |
| Testosterone | 21 | $2,440 | $116 |
| Ultra-Fine Mini Pen Needle | 22 | $2,433 | $111 |
| Levothyroxine | 209 | $2,409 | $12 |
| Metformin | 256 | $2,291 | $9 |
| Metformin Hcl Er | 177 | $2,171 | $12 |
| Cortef | 15 | $2,150 | $143 |
| Ultra-Fine Nano Pen Needle | 20 | $1,973 | $99 |
| Hydrocortisone | 23 | $1,938 | $84 |
| Ezetimibe | 20 | $1,803 | $90 |
| Methimazole | 126 | $1,112 | $9 |
| Nateglinide | 20 | $1,091 | $55 |
| Cabergoline | 15 | $1,010 | $67 |
| Repaglinide | 16 | $999 | $62 |
| Fenofibrate | 16 | $996 | $62 |
| Atorvastatin | 120 | $965 | $8 |
| Pioglitazone | 73 | $914 | $13 |
| Testosterone Cypionate | 39 | $762 | $20 |
| Alendronate | 76 | $571 | $8 |
| Ibandronate | 13 | $540 | $42 |
| Rosuvastatin | 28 | $466 | $17 |
| Glipizide | 43 | $360 | $8 |
| Gabapentin | 16 | $223 | $14 |
| Spironolactone | 18 | $207 | $11 |
| Pravastatin | 11 | $184 | $17 |
| Simvastatin | 11 | $82 | $7 |
| Glimepiride | 20 | $78 | $4 |
| Amlodipine Besylate | 14 | $15 | $1 |
Year by year
| 2024 | 4,011 | 533 | 0% (0) | 55% | $2,638,821 |
| 2023 | 3,653 | 463 | None | 59% | $3,149,042 |
| 2022 | 3,410 | 393 | 0% (0) | 60% | $2,841,107 |
| 2021 | 3,876 | 413 | 0% (0) | 60% | $2,617,593 |
| 2020 | 3,922 | 490 | None | 58% | $2,226,570 |
| 2019 | 4,805 | 534 | 0% (0) | 57% | $2,437,810 |
| 2018 | 4,198 | 422 | None | 53% | $1,740,486 |
| 2017 | 2,979 | 311 | 1% (19) | 41% | $749,667 |
| 2016 | 2,348 | 218 | 1% (12) | 36% | $411,943 |
| 2015 | 1,366 | 207 | 2% (29) | 34% | $202,481 |
| 2014 | 360 | 89 | None | 41% | $72,534 |
| 2013 | 240 | 58 | 0% (0) | 46% | $48,906 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Ozempic | 356 | $650,225 | $1,826 |
| Trulicity | 238 | $510,187 | $2,144 |
| Farxiga | 204 | $320,392 | $1,571 |
| Jardiance | 148 | $228,941 | $1,547 |
| Novolog Flexpen | 156 | $208,376 | $1,336 |
| Forteo | 29 | $165,324 | $5,701 |
| Humalog Kwikpen U-100 | 65 | $107,260 | $1,650 |
| Januvia | 62 | $100,197 | $1,616 |
| Tresiba Flextouch U-100 | 120 | $99,880 | $832 |
| Tresiba Flextouch U-200 | 39 | $74,169 | $1,902 |
| Toujeo Solostar | 101 | $70,675 | $700 |
| Rybelsus | 26 | $58,314 | $2,243 |
| Basaglar Kwikpen U-100 | 76 | $45,037 | $593 |
| Lantus Solostar | 71 | $40,105 | $565 |
| Bydureon Bcise | 19 | $26,043 | $1,371 |
| Victoza 3-Pak | 21 | $24,782 | $1,180 |
| Toujeo Max Solostar | 30 | $24,499 | $817 |
| Novolog | 22 | $22,485 | $1,022 |
| Praluent | 14 | $19,018 | $1,358 |
| Tradjenta | 20 | $18,085 | $904 |
| Humalog | 18 | $15,292 | $850 |
| Nano 2nd Gen Pen Needle | 149 | $14,567 | $98 |
| Insulin Lispro Kwikpen U-100 | 30 | $11,554 | $385 |
| Synjardy | 14 | $11,230 | $802 |
| Humulin 70/30 Kwikpen | 11 | $10,594 | $963 |
| Vascepa | 23 | $9,005 | $392 |
| Lantus | 18 | $5,359 | $298 |
| Icosapent Ethyl | 12 | $5,177 | $431 |
| Metformin | 257 | $5,080 | $20 |
| Admelog Solostar | 13 | $3,864 | $297 |
| Levothyroxine | 156 | $3,710 | $24 |
| Pioglitazone | 94 | $3,559 | $38 |
| Synthroid | 31 | $3,557 | $115 |
| Ultra-Fine Mini Pen Needle | 34 | $3,106 | $91 |
| Ultra-Fine Short Pen Needle | 27 | $2,876 | $107 |
| Ezetimibe | 25 | $2,812 | $112 |
| Comfort Ez Pen Needle | 11 | $2,412 | $219 |
| Tirosint | 11 | $2,377 | $216 |
| Hydrocortisone | 23 | $2,288 | $99 |
| Ultra-Fine Nano Pen Needle | 21 | $2,226 | $106 |
| Nateglinide | 17 | $2,175 | $128 |
| Atorvastatin | 85 | $2,042 | $24 |
| Metformin Hcl Er | 91 | $1,901 | $21 |
| Methimazole | 82 | $1,799 | $22 |
| Testosterone | 16 | $1,464 | $92 |
| Alendronate | 67 | $1,273 | $19 |
| Rosuvastatin | 21 | $1,001 | $48 |
| Pregabalin | 12 | $816 | $68 |
| Fenofibrate | 13 | $589 | $45 |
| Testosterone Cypionate | 23 | $491 | $21 |
| Glipizide | 36 | $429 | $12 |
| Amlodipine Besylate | 13 | $270 | $21 |
| Gabapentin | 15 | $180 | $12 |
2022: 53 drugs
| Trulicity | 290 | $526,871 | $1,817 |
| Ozempic | 249 | $423,111 | $1,699 |
| Farxiga | 168 | $260,304 | $1,549 |
| Novolog Flexpen | 147 | $220,752 | $1,502 |
| Jardiance | 131 | $192,329 | $1,468 |
| Forteo | 28 | $119,040 | $4,251 |
| Tresiba Flextouch U-200 | 47 | $91,550 | $1,948 |
| Humalog Kwikpen U-100 | 56 | $85,715 | $1,531 |
| Tresiba Flextouch U-100 | 87 | $83,457 | $959 |
| Januvia | 46 | $66,073 | $1,436 |
| Lantus Solostar | 99 | $63,405 | $640 |
| Toujeo Solostar | 95 | $55,128 | $580 |
| Bydureon Bcise | 30 | $50,595 | $1,686 |
| Humalog | 23 | $47,863 | $2,081 |
| Invokana | 32 | $47,003 | $1,469 |
| Tymlos | 14 | $41,819 | $2,987 |
| Basaglar Kwikpen U-100 | 65 | $41,156 | $633 |
| Rybelsus | 16 | $40,576 | $2,536 |
| Victoza 3-Pak | 25 | $35,320 | $1,413 |
| Tradjenta | 28 | $30,463 | $1,088 |
| Teriparatide | 11 | $29,403 | $2,673 |
| Toujeo Max Solostar | 25 | $22,840 | $914 |
| Novolog | 20 | $19,700 | $985 |
| Insulin Lispro Kwikpen U-100 | 43 | $15,478 | $360 |
| Vascepa | 20 | $9,351 | $468 |
| Androderm | 12 | $8,063 | $672 |
| Nano 2nd Gen Pen Needle | 88 | $7,827 | $89 |
| Lantus | 14 | $7,184 | $513 |
| Icosapent Ethyl | 14 | $7,114 | $508 |
| Ultra-Fine Mini Pen Needle | 70 | $5,680 | $81 |
| Cinacalcet | 16 | $4,067 | $254 |
| Synthroid | 38 | $3,514 | $92 |
| Ultra-Fine Short Pen Needle | 28 | $3,361 | $120 |
| Levothyroxine | 145 | $3,303 | $23 |
| Pioglitazone | 109 | $3,135 | $29 |
| Metformin | 230 | $2,450 | $11 |
| Ezetimibe | 22 | $1,910 | $87 |
| Nateglinide | 17 | $1,840 | $108 |
| Ultra-Fine Nano Pen Needle | 19 | $1,794 | $94 |
| Cortef | 13 | $1,515 | $117 |
| Fenofibrate | 13 | $1,389 | $107 |
| Atorvastatin | 87 | $1,367 | $16 |
| Methimazole | 76 | $1,244 | $16 |
| Metformin Hcl Er | 88 | $1,211 | $14 |
| Ibandronate | 13 | $1,184 | $91 |
| Alendronate | 67 | $1,084 | $16 |
| Rosuvastatin | 15 | $779 | $52 |
| Testosterone Cypionate | 30 | $734 | $24 |
| Gabapentin | 18 | $337 | $19 |
| Glipizide | 31 | $137 | $4 |
| Glimepiride | 12 | $124 | $10 |
| Lisinopril | 11 | $73 | $7 |
| Amlodipine Besylate | 11 | $68 | $6 |
2021: 57 drugs
| Trulicity | 437 | $562,521 | $1,287 |
| Ozempic | 219 | $286,523 | $1,308 |
| Novolog Flexpen | 166 | $226,865 | $1,367 |
| Jardiance | 126 | $174,425 | $1,384 |
| Humalog Kwikpen U-100 | 105 | $139,541 | $1,329 |
| Farxiga | 113 | $138,329 | $1,224 |
| Januvia | 70 | $90,717 | $1,296 |
| Lantus Solostar | 126 | $84,401 | $670 |
| Toujeo Solostar | 128 | $82,089 | $641 |
| Forteo | 20 | $79,610 | $3,981 |
| Victoza 3-Pak | 28 | $64,358 | $2,299 |
| Tresiba Flextouch U-100 | 94 | $64,270 | $684 |
| Tresiba Flextouch U-200 | 27 | $51,612 | $1,912 |
| Invokana | 40 | $49,270 | $1,232 |
| Tradjenta | 43 | $48,117 | $1,119 |
| Humalog | 34 | $46,502 | $1,368 |
| Basaglar Kwikpen U-100 | 88 | $46,283 | $526 |
| Bydureon Bcise | 30 | $43,487 | $1,450 |
| Tymlos | 13 | $29,431 | $2,264 |
| Novolog | 34 | $26,386 | $776 |
| Insulin Lispro Kwikpen U-100 | 39 | $25,964 | $666 |
| Humalog Mix 75-25 | 15 | $17,882 | $1,192 |
| Toujeo Max Solostar | 27 | $16,499 | $611 |
| Vascepa | 26 | $16,079 | $618 |
| Insulin Aspart Flexpen | 14 | $13,159 | $940 |
| Nano 2nd Gen Pen Needle | 119 | $9,129 | $77 |
| Androderm | 11 | $7,282 | $662 |
| Ultra-Fine Mini Pen Needle | 83 | $6,422 | $77 |
| Admelog Solostar | 11 | $6,271 | $570 |
| Lantus | 15 | $5,301 | $353 |
| Levothyroxine | 171 | $4,525 | $26 |
| Ultra-Fine Short Pen Needle | 38 | $4,099 | $108 |
| Ultra-Fine Nano Pen Needle | 43 | $3,512 | $82 |
| Testosterone | 12 | $3,143 | $262 |
| Nateglinide | 26 | $3,045 | $117 |
| Metformin | 259 | $2,555 | $10 |
| Pioglitazone | 110 | $2,352 | $21 |
| Ezetimibe | 22 | $2,079 | $94 |
| Cortef | 23 | $2,012 | $87 |
| Synthroid | 20 | $1,834 | $92 |
| Atorvastatin | 86 | $1,734 | $20 |
| Cabergoline | 14 | $1,635 | $117 |
| Methimazole | 93 | $1,569 | $17 |
| Fenofibrate | 17 | $1,566 | $92 |
| Liothyronine | 11 | $1,230 | $112 |
| Droplet Pen Needle | 16 | $1,141 | $71 |
| Metformin Hcl Er | 88 | $1,056 | $12 |
| Ultra-Fine Original Pen Needle | 11 | $904 | $82 |
| Rosuvastatin | 11 | $611 | $56 |
| Alendronate | 51 | $505 | $10 |
| Testosterone Cypionate | 14 | $282 | $20 |
| Glipizide | 38 | $276 | $7 |
| Glimepiride | 20 | $262 | $13 |
| Gabapentin | 15 | $201 | $13 |
| Euthyrox | 12 | $196 | $16 |
| Atenolol | 14 | $117 | $8 |
| Amlodipine Besylate | 14 | $68 | $5 |
2020: 53 drugs
| Trulicity | 411 | $489,427 | $1,191 |
| Ozempic | 257 | $281,918 | $1,097 |
| Jardiance | 205 | $207,986 | $1,015 |
| Novolog Flexpen | 143 | $138,366 | $968 |
| Humalog Kwikpen U-100 | 97 | $115,272 | $1,188 |
| Toujeo Solostar | 131 | $98,226 | $750 |
| Lantus Solostar | 122 | $75,484 | $619 |
| Januvia | 68 | $75,345 | $1,108 |
| Tymlos | 19 | $68,444 | $3,602 |
| Victoza 3-Pak | 31 | $65,035 | $2,098 |
| Tresiba Flextouch U-100 | 85 | $49,385 | $581 |
| Invokana | 47 | $48,630 | $1,035 |
| Tradjenta | 45 | $41,899 | $931 |
| Farxiga | 37 | $41,326 | $1,117 |
| Basaglar Kwikpen U-100 | 79 | $38,026 | $481 |
| Toujeo Max Solostar | 30 | $25,444 | $848 |
| Tresiba Flextouch U-200 | 16 | $23,866 | $1,492 |
| Insulin Lispro Kwikpen U-100 | 33 | $20,143 | $610 |
| Victoza 2-Pak | 21 | $19,557 | $931 |
| Novolog | 26 | $17,181 | $661 |
| Soliqua 100-33 | 12 | $16,919 | $1,410 |
| Vascepa | 27 | $16,766 | $621 |
| Humalog | 16 | $13,589 | $849 |
| Ultra-Fine Nano Pen Needle | 139 | $10,305 | $74 |
| Praluent | 19 | $9,664 | $509 |
| Insulin Aspart Flexpen | 14 | $9,055 | $647 |
| Novolog Mix 70-30 Flexpen | 14 | $8,670 | $619 |
| Cinacalcet | 13 | $8,152 | $627 |
| Ultra-Fine Mini Pen Needle | 91 | $6,134 | $67 |
| Levothyroxine | 192 | $5,978 | $31 |
| Admelog Solostar | 15 | $3,767 | $251 |
| Ultra-Fine Short Pen Needle | 37 | $3,727 | $101 |
| Nateglinide | 28 | $3,333 | $119 |
| Pioglitazone | 113 | $2,475 | $22 |
| Metformin | 233 | $2,268 | $10 |
| Ezetimibe | 33 | $2,122 | $64 |
| Atorvastatin | 122 | $1,928 | $16 |
| Fenofibrate | 17 | $1,592 | $94 |
| Nano 2nd Gen Pen Needle | 20 | $1,548 | $77 |
| Metformin Hcl Er | 118 | $1,541 | $13 |
| Repaglinide | 24 | $1,494 | $62 |
| Rosuvastatin | 19 | $1,387 | $73 |
| Methimazole | 67 | $1,306 | $19 |
| Synthroid | 15 | $1,230 | $82 |
| Testosterone Cypionate | 14 | $541 | $39 |
| Hydrocortisone | 11 | $405 | $37 |
| Alendronate | 39 | $329 | $8 |
| Glipizide | 32 | $279 | $9 |
| Glimepiride | 28 | $196 | $7 |
| Glipizide Er | 11 | $186 | $17 |
| Gabapentin | 17 | $123 | $7 |
| Amlodipine Besylate | 18 | $79 | $4 |
| Dexamethasone | 15 | $25 | $2 |
2019: 63 drugs
| Trulicity | 496 | $499,756 | $1,008 |
| Novolog Flexpen | 231 | $234,721 | $1,016 |
| Forteo | 50 | $176,091 | $3,522 |
| Jardiance | 203 | $159,505 | $786 |
| Ozempic | 157 | $154,160 | $982 |
| Humalog Kwikpen U-100 | 141 | $146,729 | $1,041 |
| Toujeo Solostar | 193 | $139,279 | $722 |
| Victoza 3-Pak | 70 | $121,507 | $1,736 |
| Januvia | 111 | $101,860 | $918 |
| Lantus Solostar | 120 | $59,924 | $499 |
| Tradjenta | 78 | $54,524 | $699 |
| Tresiba Flextouch U-100 | 102 | $47,526 | $466 |
| Invokana | 55 | $46,263 | $841 |
| Tresiba Flextouch U-200 | 22 | $37,788 | $1,718 |
| Farxiga | 41 | $37,294 | $910 |
| Basaglar Kwikpen U-100 | 102 | $32,930 | $323 |
| Novolog | 37 | $30,748 | $831 |
| Praluent | 23 | $25,919 | $1,127 |
| Bydureon Bcise | 33 | $24,591 | $745 |
| Victoza 2-Pak | 17 | $19,431 | $1,143 |
| Humalog | 17 | $18,872 | $1,110 |
| Bydureon | 24 | $18,597 | $775 |
| Ultra-Fine Nano Pen Needle | 213 | $15,687 | $74 |
| Prolia | 12 | $14,767 | $1,231 |
| Vascepa | 23 | $12,980 | $564 |
| Levemir Flextouch | 19 | $8,071 | $425 |
| Nateglinide | 55 | $6,958 | $127 |
| Invokamet | 11 | $5,285 | $480 |
| Ultra-Fine Mini Pen Needle | 70 | $5,080 | $73 |
| Levothyroxine | 177 | $5,079 | $29 |
| Admelog Solostar | 17 | $4,899 | $288 |
| Easy Comfort Pen Needles | 17 | $3,069 | $181 |
| Metformin | 300 | $3,055 | $10 |
| Pioglitazone | 180 | $3,049 | $17 |
| Atorvastatin | 149 | $2,559 | $17 |
| Comfort Ez Pen Needle | 16 | $1,906 | $119 |
| Synthroid | 24 | $1,884 | $78 |
| Ultra-Fine Short Pen Needle | 21 | $1,879 | $89 |
| Metformin Hcl Er | 157 | $1,866 | $12 |
| Rosuvastatin | 27 | $1,519 | $56 |
| Repaglinide | 22 | $954 | $43 |
| Gabapentin | 25 | $925 | $37 |
| Methimazole | 55 | $924 | $17 |
| Ulticare Pen Needle | 19 | $820 | $43 |
| Ezetimibe | 38 | $765 | $20 |
| Hydrocortisone | 23 | $669 | $29 |
| Novolin 70-30 | 11 | $647 | $59 |
| Glimepiride | 51 | $556 | $11 |
| Amlodipine Besylate | 61 | $537 | $9 |
| Liothyronine | 13 | $515 | $40 |
| Sure Comfort | 16 | $496 | $31 |
| Losartan | 29 | $458 | $16 |
| Unifine Pentips | 19 | $437 | $23 |
| Glipizide | 41 | $395 | $10 |
| Lisinopril | 30 | $340 | $11 |
| Alendronate | 28 | $338 | $12 |
| Pravastatin | 16 | $301 | $19 |
| Testosterone Cypionate | 18 | $289 | $16 |
| Simvastatin | 23 | $237 | $10 |
| Glipizide Er | 13 | $150 | $12 |
| Metoprolol | 24 | $109 | $5 |
| Omeprazole | 12 | $52 | $4 |
| Dexamethasone | 22 | $45 | $2 |
2018: 61 drugs
| Trulicity | 358 | $320,187 | $894 |
| Toujeo Solostar | 275 | $153,017 | $556 |
| Novolog Flexpen | 171 | $152,737 | $893 |
| Victoza 3-Pak | 96 | $124,775 | $1,300 |
| Humalog Kwikpen U-100 | 125 | $112,712 | $902 |
| Forteo | 30 | $99,145 | $3,305 |
| Januvia | 132 | $97,892 | $742 |
| Tradjenta | 113 | $81,788 | $724 |
| Invokana | 79 | $59,839 | $757 |
| Jardiance | 69 | $52,212 | $757 |
| Tresiba Flextouch U-100 | 94 | $48,457 | $516 |
| Lantus Solostar | 105 | $38,752 | $369 |
| Bydureon | 41 | $31,249 | $762 |
| Tresiba Flextouch U-200 | 26 | $27,639 | $1,063 |
| Novolog | 40 | $26,728 | $668 |
| Humalog | 34 | $25,800 | $759 |
| Farxiga | 31 | $19,973 | $644 |
| Bydureon Bcise | 24 | $15,932 | $664 |
| Basaglar Kwikpen U-100 | 40 | $14,416 | $360 |
| Prolia | 12 | $14,093 | $1,174 |
| Levemir Flextouch | 24 | $13,335 | $556 |
| Ultra-Fine Nano Pen Needle | 176 | $12,726 | $72 |
| Victoza 2-Pak | 13 | $10,220 | $786 |
| Nateglinide | 71 | $8,657 | $122 |
| Tanzeum | 11 | $5,785 | $526 |
| Lantus | 11 | $4,666 | $424 |
| Levothyroxine | 138 | $3,976 | $29 |
| Omega-3 Acid Ethyl Esters | 13 | $3,308 | $254 |
| Ultra-Fine Mini Pen Needle | 51 | $3,177 | $62 |
| Ezetimibe | 36 | $2,799 | $78 |
| Atorvastatin | 152 | $2,596 | $17 |
| Metformin | 265 | $2,409 | $9 |
| Novolin N | 13 | $2,180 | $168 |
| Pioglitazone | 149 | $2,031 | $14 |
| Ultra-Fine Short Pen Needle | 32 | $1,749 | $55 |
| Synthroid | 18 | $1,298 | $72 |
| Gabapentin | 16 | $1,122 | $70 |
| Ulticare Pen Needle | 24 | $1,099 | $46 |
| Repaglinide | 29 | $1,047 | $36 |
| Metformin Hcl Er | 111 | $933 | $8 |
| Rosuvastatin | 20 | $888 | $44 |
| Hydrocortisone | 31 | $867 | $28 |
| Glimepiride | 69 | $818 | $12 |
| Methimazole | 66 | $793 | $12 |
| Sure Comfort | 20 | $609 | $30 |
| Unifine Pentips | 19 | $453 | $24 |
| Insulin | 15 | $451 | $30 |
| Liothyronine | 17 | $448 | $26 |
| Glipizide Er | 13 | $426 | $33 |
| Amlodipine Besylate | 63 | $390 | $6 |
| Pravastatin | 15 | $367 | $24 |
| Simvastatin | 40 | $351 | $9 |
| Losartan | 35 | $325 | $9 |
| Easy Touch Pen Needle | 13 | $256 | $20 |
| Lisinopril | 33 | $248 | $8 |
| Glipizide | 23 | $236 | $10 |
| Clopidogrel | 11 | $122 | $11 |
| Alendronate | 12 | $106 | $9 |
| Atenolol | 15 | $92 | $6 |
| Metoprolol | 18 | $73 | $4 |
| Dexamethasone | 12 | $46 | $4 |
2017: 54 drugs
| Novolog Flexpen | 84 | $62,727 | $747 |
| Victoza 3-Pak | 62 | $60,774 | $980 |
| Humalog Kwikpen U-100 | 64 | $58,048 | $907 |
| Toujeo Solostar | 134 | $57,169 | $427 |
| Januvia | 64 | $39,118 | $611 |
| Tradjenta | 67 | $37,661 | $562 |
| Trulicity | 49 | $33,377 | $681 |
| Lantus Solostar | 81 | $30,980 | $382 |
| Jardiance | 59 | $30,450 | $516 |
| Tresiba Flextouch U-200 | 31 | $24,972 | $806 |
| Tresiba Flextouch U-100 | 42 | $24,002 | $571 |
| Bydureon | 38 | $23,652 | $622 |
| Metformin Hcl Er | 56 | $22,930 | $409 |
| Invokana | 42 | $21,485 | $512 |
| Novolog | 33 | $18,432 | $559 |
| Levemir Flextouch | 25 | $16,780 | $671 |
| Tanzeum | 22 | $11,220 | $510 |
| Humalog | 13 | $10,381 | $799 |
| Humulin R U-500 Kwikpen | 14 | $8,029 | $573 |
| Ultra-Fine Nano Pen Needle | 114 | $6,238 | $55 |
| Omega-3 Acid Ethyl Esters | 13 | $3,738 | $288 |
| Levothyroxine | 121 | $3,062 | $25 |
| Ultra-Fine Mini Pen Needle | 31 | $1,914 | $62 |
| Bd Ultra-Fine Pen Needle | 14 | $1,826 | $130 |
| Metoprolol | 26 | $1,520 | $58 |
| Metformin | 186 | $1,438 | $8 |
| Atorvastatin | 95 | $1,437 | $15 |
| Ezetimibe | 12 | $1,356 | $113 |
| Pioglitazone | 124 | $1,311 | $11 |
| Rosuvastatin | 27 | $1,273 | $47 |
| Glimepiride | 81 | $1,039 | $13 |
| Ultra-Fine Short Pen Needle | 17 | $1,010 | $59 |
| Synthroid | 16 | $863 | $54 |
| Duloxetine | 15 | $661 | $44 |
| Methimazole | 38 | $549 | $14 |
| Pravastatin | 33 | $511 | $15 |
| Gabapentin | 44 | $475 | $11 |
| Unifine Pentips | 18 | $428 | $24 |
| Sure Comfort | 13 | $405 | $31 |
| Losartan | 20 | $273 | $14 |
| Simvastatin | 40 | $266 | $7 |
| Lisinopril | 69 | $264 | $4 |
| Glipizide | 40 | $246 | $6 |
| Glipizide Er | 15 | $226 | $15 |
| Amlodipine Besylate | 53 | $220 | $4 |
| Hydrocodone-Acetaminophen | 13 | $215 | $17 |
| Omeprazole | 23 | $211 | $9 |
| Clopidogrel | 19 | $201 | $11 |
| Carvedilol | 18 | $191 | $11 |
| Warfarin | 12 | $125 | $10 |
| Furosemide | 31 | $111 | $4 |
| Donepezil | 16 | $102 | $6 |
| Metoprolol | 18 | $97 | $5 |
| Dexamethasone | 15 | $51 | $3 |
2016: 54 drugs
| Victoza 3-Pak | 38 | $38,527 | $1,014 |
| Lantus Solostar | 88 | $38,246 | $435 |
| Humalog Kwikpen U-100 | 56 | $37,063 | $662 |
| Novolog Flexpen | 48 | $26,605 | $554 |
| Januvia | 54 | $22,608 | $419 |
| Toujeo Solostar | 25 | $15,037 | $601 |
| Bydureon | 22 | $14,140 | $643 |
| Tresiba Flextouch U-100 | 25 | $13,510 | $540 |
| Tanzeum | 26 | $12,728 | $490 |
| Novolog | 23 | $12,419 | $540 |
| Tradjenta | 16 | $10,943 | $684 |
| Novolog Mix 70-30 | 14 | $7,548 | $539 |
| Metformin Hcl Er | 14 | $7,280 | $520 |
| Humulin 70-30 | 22 | $7,251 | $330 |
| Humalog | 17 | $7,242 | $426 |
| Levemir Flextouch | 16 | $7,200 | $450 |
| Sensipar | 12 | $6,892 | $574 |
| Crestor | 19 | $6,259 | $329 |
| Bd Ultra-Fine Pen Needle | 111 | $5,656 | $51 |
| Invokana | 14 | $5,483 | $392 |
| Zetia | 19 | $5,229 | $275 |
| Lantus | 14 | $4,017 | $287 |
| Levothyroxine | 91 | $1,968 | $22 |
| Atorvastatin | 80 | $927 | $12 |
| Glimepiride | 78 | $897 | $12 |
| Pioglitazone | 66 | $787 | $12 |
| Pravastatin | 35 | $772 | $22 |
| Insulin | 15 | $680 | $45 |
| Metformin | 118 | $608 | $5 |
| Metoprolol | 15 | $591 | $39 |
| Synthroid | 13 | $545 | $42 |
| Glipizide Er | 17 | $430 | $25 |
| Gabapentin | 53 | $423 | $8 |
| Amlodipine Besylate | 78 | $388 | $5 |
| Lisinopril | 66 | $255 | $4 |
| Potassium Chloride | 17 | $249 | $15 |
| Omeprazole | 17 | $207 | $12 |
| Furosemide | 51 | $201 | $4 |
| Methimazole | 13 | $165 | $13 |
| Simvastatin | 29 | $151 | $5 |
| Clopidogrel | 18 | $146 | $8 |
| Loperamide | 12 | $144 | $12 |
| Hydralazine | 11 | $139 | $13 |
| Alendronate | 22 | $138 | $6 |
| Irbesartan | 12 | $136 | $11 |
| Hydrochlorothiazide | 17 | $133 | $8 |
| Glipizide | 22 | $126 | $6 |
| Metoprolol | 20 | $113 | $6 |
| Quetiapine | 14 | $101 | $7 |
| Ciprofloxacin | 17 | $97 | $6 |
| Lovastatin | 14 | $86 | $6 |
| Famotidine | 11 | $82 | $7 |
| Benazepril | 11 | $44 | $4 |
| Donepezil | 11 | $43 | $4 |
2015: 30 drugs
| Lantus Solostar | 43 | $22,271 | $518 |
| Humalog Kwikpen U-100 | 30 | $19,897 | $663 |
| Victoza 3-Pak | 22 | $19,816 | $901 |
| Novolog Flexpen | 36 | $18,180 | $505 |
| Levemir Flextouch | 18 | $9,613 | $534 |
| Bydureon | 13 | $8,459 | $651 |
| Januvia | 17 | $7,056 | $415 |
| Lantus | 14 | $4,764 | $340 |
| Novolog | 13 | $3,668 | $282 |
| Zetia | 13 | $3,059 | $235 |
| Bd Ultra-Fine Pen Needle | 42 | $1,807 | $43 |
| Levothyroxine | 36 | $769 | $21 |
| Pravastatin | 14 | $487 | $35 |
| Metformin | 86 | $477 | $6 |
| Glimepiride | 65 | $444 | $7 |
| Atorvastatin | 34 | $418 | $12 |
| Pioglitazone | 29 | $356 | $12 |
| Hydrocodone-Acetaminophen | 16 | $314 | $20 |
| Gabapentin | 40 | $263 | $7 |
| Amlodipine Besylate | 53 | $236 | $4 |
| Clonidine | 16 | $196 | $12 |
| Azithromycin | 22 | $176 | $8 |
| Ciprofloxacin | 23 | $157 | $7 |
| Lisinopril | 34 | $157 | $5 |
| Synthroid | 11 | $147 | $13 |
| Simvastatin | 24 | $101 | $4 |
| Furosemide | 26 | $88 | $3 |
| Potassium Chloride | 13 | $87 | $7 |
| Hydrochlorothiazide | 13 | $75 | $6 |
| Metoprolol | 14 | $51 | $4 |
2014: 10 drugs
| Humalog | 31 | $15,805 | $510 |
| Lantus | 21 | $10,878 | $518 |
| Lantus Solostar | 24 | $9,257 | $386 |
| Novolog Flexpen | 13 | $7,045 | $542 |
| Bd Ultra-Fine Pen Needle | 28 | $1,305 | $47 |
| Atorvastatin | 20 | $831 | $42 |
| Levothyroxine | 11 | $197 | $18 |
| Metformin | 24 | $188 | $8 |
| Glimepiride | 16 | $168 | $10 |
| Amlodipine Besylate | 12 | $84 | $7 |
2013: 6 drugs
| Humalog | 27 | $10,539 | $390 |
| Lantus | 16 | $5,747 | $359 |
| Levemir | 11 | $5,375 | $489 |
| Bd Ultra-Fine Pen Needle | 21 | $1,080 | $51 |
| Insulin | 17 | $594 | $35 |
| Methimazole | 24 | $197 | $8 |
Money from drug and device companies
$2,204 in 2025
| 2025 | 43 | 98 | None | $2,204 |
| 2024 | 30 | 62 | None | $1,424 |
| 2023 | 22 | 61 | None | $1,326 |
| 2022 | 12 | 39 | None | $868 |
| 2021 | 9 | 48 | None | $1,032 |
| 2020 | 14 | 69 | None | $1,199 |
| 2019 | 21 | 158 | None | $2,356 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $323 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Calquence | $209 | 9 payments
|
| Radius Health | None | $142 | 8 payments
|
| Amgen | Tepezza | $131 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $73 | 3 payments
|
| Novartis Pharmaceuticals | Kisqali | $69 | 2 payments
|
See all 95 published payments
| Beta Bionics | Meals · 2025-12-16 | Ilet Bionic Pancreas | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-03 | Imfinzi | $16 |
| Amgen | Meals · 2025-12-02 | Tepezza | $30 |
| Genentech USA | Meals · 2025-11-19 | Tecentriq Hybreza | $34 |
| Pharmacosmos Therapeutics | Meals · 2025-10-31 | Monoferric | $27 |
| Optos | Entertainment · 2025-10-28 | Oct Ophthalmoscope | $21 |
| Novo Nordisk | Meals · 2025-10-24 | Wegovy | $12 |
| Stemline Therapeutics | Meals · 2025-10-17 | Orserdu | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Calquence | $26 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-15 | Tagrisso | $33 |
| Madrigal Pharmaceuticals | Meals · 2025-10-14 | Rezdiffra | $33 |
| Tempus AI | Meals · 2025-10-14 | Xt Cdx | $22 |
| Novo Nordisk | Meals · 2025-10-07 | Wegovy | $17 |
| Abbott Laboratories | Meals · 2025-10-07 | Freestyle Libre 3 | $24 |
| Novo Nordisk | Meals · 2025-10-02 | Rybelsus | $8 |
| Medtronic | Meals · 2025-09-30 | Minimed 780g | $18 |
| Daiichi Sankyo | Meals · 2025-09-25 | Enhertu | $29 |
| Amgen | Meals · 2025-09-23 | Tepezza | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-09-22 | Libtayo | $31 |
| Daiichi Sankyo | Meals · 2025-09-10 | Datroway | $19 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-09-09 | Jardiance | $24 |
| Aveo Pharmaceuticals | Meals · 2025-09-05 | Fotivda | $26 |
| Tempus AI | Meals · 2025-09-05 | Xt Cdx | $24 |
| Dexcom | Meals · 2025-09-02 | Dexcom G6 Transmitter | $21 |
| Stemline Therapeutics | Meals · 2025-08-27 | Orserdu | $24 |
| Genentech USA | Meals · 2025-08-25 | Tecentriq | $32 |
| Janssen Biotech | Meals · 2025-08-15 | Rybrevant | $30 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-12 | Kerendia | $21 |
| Merck Sharp & Dohme | Meals · 2025-08-07 | Keytruda | $19 |
| Novo Nordisk | Meals · 2025-08-05 | Rybelsus | $23 |
| Pharmacosmos Therapeutics | Meals · 2025-07-30 | Monoferric | $20 |
| Almatica Pharma | Meals · 2025-07-29 | Loreev Xr | $15 |
| Ascendis Pharma Endocrinology | Meals · 2025-07-01 | Yorvipath | $26 |
| Blueprint Medicines | Meals · 2025-06-30 | Ayvakit | $60 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-26 | Tagrisso | $32 |
| Novo Nordisk | Meals · 2025-06-18 | Wegovy | $23 |
| Dexcom | Meals · 2025-06-10 | Dexcom G6 Transmitter | $21 |
| Novo Nordisk | Meals · 2025-06-09 | Rybelsus | $22 |
| Amgen | Meals · 2025-06-03 | Tepezza | $22 |
| Abbvie | Meals · 2025-06-02 | Epkinly | $28 |
| PharmaEssentia USA | Meals · 2025-05-30 | Besremi | $26 |
| BeOne Medicines USA | Meals · 2025-05-28 | Brukinsa | $31 |
| Sanofi-Aventis U.S. | Meals · 2025-05-27 | Tzield | $20 |
| Novo Nordisk | Meals · 2025-05-23 | Rybelsus | $5 |
| Novo Nordisk | Meals · 2025-05-22 | Ozempic | $103 |
| Radius Health | Meals · 2025-05-20 | None | $24 |
| Radius Health | Meals · 2025-05-20 | None | $19 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-05-19 | Iclusig | $25 |
| Legend Biotech USA | Meals · 2025-05-16 | Carvykti | $19 |
| Fresenius Kabi USA | Meals · 2025-05-16 | Stimufend | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-07 | Calquence | $23 |
| Novo Nordisk | Meals · 2025-04-29 | Ozempic | $6 |
| Radius Health | Meals · 2025-04-29 | None | $30 |
| Lilly USA | Meals · 2025-04-23 | Mounjaro | $14 |
| Iovance Biotherapeutics | Meals · 2025-04-23 | Amtagvi | $21 |
| Amneal Pharmaceuticals | Meals · 2025-04-16 | Alymsys | $29 |
| Novo Nordisk | Meals · 2025-04-15 | Rybelsus | $8 |
| Medtronic | Meals · 2025-04-15 | Minimed 780g | $14 |
| Xeris Pharmaceuticals | Meals · 2025-04-08 | Recorlev | $19 |
| Ascendis Pharma Endocrinology | Meals · 2025-04-04 | Yorvipath | $24 |
| Agios Pharmaceuticals | Meals · 2025-04-04 | Pyrukynd | $16 |
| Janssen Biotech | Meals · 2025-04-03 | Carvykti | $22 |
| Mannkind | Meals · 2025-04-01 | Afrezza | $20 |
| Merck Sharp & Dohme | Meals · 2025-03-27 | Keytruda | $29 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-26 | Imfinzi | $21 |
| Amgen | Meals · 2025-03-26 | Evenity | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-24 | Imfinzi | $10 |
| Abbvie | Meals · 2025-03-19 | Mavyret | $23 |
| Novo Nordisk | Meals · 2025-03-18 | Ozempic | $24 |
| Amgen | Meals · 2025-03-11 | Tepezza | $19 |
| Radius Health | Meals · 2025-03-04 | None | $30 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-03 | Ninlaro | $23 |
| Agios Pharmaceuticals | Meals · 2025-02-28 | Pyrukynd | $17 |
| Genmab U.S. | Meals · 2025-02-27 | Epkinly | $26 |
| Eisai | Meals · 2025-02-21 | Lenvima | $29 |
| Radius Health | Meals · 2025-02-20 | None | $3 |
| Radius Health | Meals · 2025-02-20 | None | $7 |
| Radius Health | Meals · 2025-02-20 | None | $6 |
| Novo Nordisk | Meals · 2025-02-19 | Ozempic | $17 |
| Novartis Pharmaceuticals | Meals · 2025-02-12 | Kisqali | $35 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | Airsupra | $23 |
| Azurity Pharmaceuticals | Meals · 2025-02-07 | Danziten | $21 |
| Novo Nordisk | Meals · 2025-02-05 | Ozempic | $15 |
| Novo Nordisk | Meals · 2025-02-04 | Rybelsus | $12 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-30 | Calquence | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-28 | Kerendia | $32 |
| Radius Health | Meals · 2025-01-25 | None | $23 |
| BeiGene USA | Meals · 2025-01-23 | Brukinsa | $18 |
| Sobi | Meals · 2025-01-15 | Vonjo | $28 |
| Novo Nordisk | Meals · 2025-01-14 | Ozempic | $20 |
| Novartis Pharmaceuticals | Meals · 2025-01-10 | Lutathera | $34 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-08 | Ninlaro | $25 |
| Amgen | Meals · 2025-01-08 | Tepezza | $25 |
| Novo Nordisk | Meals · 2025-01-07 | Ozempic | $9 |
| Xeris Pharmaceuticals | Meals · 2025-01-07 | Recorlev | $34 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,424
| Merck Sharp & Dohme | Keytruda | $196 | 7 payments
|
| Lilly USA | Mounjaro | $129 | 5 payments
|
| Abbvie | Synthroid | $79 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $73 | 3 payments
|
| Amgen | Repatha | $70 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $69 | 3 payments
|
| Coherus Biosciences | Udenyca | $62 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Breztri | $62 | 3 payments
|
| Dexcom | Dexcom G6 Transmitter | $58 | 3 payments
|
| Astellas Pharma US | Veozah | $57 | 2 payments
|
| Kyowa Kirin | Crysvita | $56 | 3 payments
|
| Regeneron Healthcare Solutions | Libtayo | $55 | 2 payments
|
| Pfizer | Prevnar 20 | $44 | 2 payments
|
| ADC Therapeutics America | None | $43 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Ninlaro | $38 | 2 payments
|
| Sanofi-Aventis U.S. | Tzield | $36 | 2 payments
|
| Alexion Pharmaceuticals | Ultomiris | $33 | 1 payment
|
| Janssen Biotech | Tecvayli | $29 | 1 payment
|
| Amneal Pharmaceuticals | Avastin | $25 | 1 payment
|
| Medtronic | Minimed 780g | $23 | 1 payment
|
| Beta Bionics | Ilet Bionic Pancreas | $23 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $23 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $21 | 1 payment
|
| Azurity Pharmaceuticals | Vivimusta | $21 | 1 payment
|
| BeiGene USA | Brukinsa | $20 | 1 payment
|
| Genentech USA | Itovebi | $20 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $18 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $14 | 1 payment
|
| Novo Nordisk | Ozempic | $14 | 1 payment
|
| Radius Health | None | $13 | 1 payment
|
2023: $1,326
| Novo Nordisk | Ozempic | $259 | 14 payments
|
| Lilly USA | Trulicity | $167 | 8 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $120 | 5 payments
|
| Janssen Biotech | Darzalex | $102 | 4 payments
|
| Merck Sharp & Dohme | Keytruda | $87 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $74 | 4 payments
|
| Genentech USA | Alecensa | $60 | 2 payments
|
| Regeneron Healthcare Solutions | Libtayo | $57 | 2 payments
|
| Radius Health | None | $48 | 3 payments
|
| GlaxoSmithKline | Shingrix | $47 | 2 payments
|
| Pharmacosmos Therapeutics | Monoferric | $46 | 2 payments
|
| MannKind | Afrezza | $40 | 2 payments
|
| Coherus Biosciences | Udenyca | $29 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $24 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $23 | 1 payment
|
| Pfizer | Somavert | $23 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $22 | 1 payment
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $22 | 1 payment
|
| Daiichi Sankyo | Enhertu | $22 | 1 payment
|
| CeQur | Cequr Simplicity | $18 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $18 | 1 payment
|
| Amgen | Lumakras | $17 | 1 payment
|
2022: $868
| Novo Nordisk | Rybelsus | $243 | 9 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $104 | 5 payments
|
| Janssen Biotech | Darzalex | $96 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $72 | 4 payments
|
| Lilly USA | Mounjaro | $66 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $65 | 4 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $64 | 3 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $39 | 2 payments
|
| GlaxoSmithKline | Blenrep | $39 | 2 payments
|
| Amgen | Kyprolis | $33 | 1 payment
|
| Mannkind | Afrezza | $31 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $16 | 1 payment
|
2021: $1,032
| Novo Nordisk | Ozempic | $230 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $171 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $171 | 9 payments
|
| Lilly USA | Baqsimi | $153 | 8 payments
|
| Merck Sharp & Dohme | Januvia | $107 | 7 payments
|
| Medtronic | Inpen | $101 | 1 payment
|
| Corcept Therapeutics | Korlym | $46 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $32 | 2 payments
|
| Insulet | Omnipod | $21 | 1 payment
|
2020: $1,199
| AstraZeneca Pharmaceuticals LP | Farxiga | $315 | 11 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $159 | 9 payments
|
| Janssen Pharmaceuticals | Invokana | $148 | 9 payments
|
| Amarin Pharma | Vascepa | $127 | 9 payments
|
| Lilly USA | Trulicity | $126 | 7 payments
|
| Merck Sharp & Dohme | Januvia | $96 | 6 payments
|
| Corcept Therapeutics | Korlym | $72 | 3 payments
|
| Novo Nordisk | Ozempic | $45 | 3 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $34 | 2 payments
|
| iRhythm Technologies | Zio Patch | $18 | 1 payment
|
| Mannkind | Afrezza | $18 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $15 | 1 payment
|
| Insulet | Omnipod | $14 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump | $11 | 1 payment
|
2019: $2,356
| AstraZeneca Pharmaceuticals LP | Farxiga | $443 | 17 payments
|
| Novo Nordisk | Ozempic | $319 | 29 payments
|
| Lilly USA | Trulicity | $255 | 20 payments
|
| Medtronic MiniMed | Minimed 670g System | $200 | 2 payments
|
| Merck Sharp & Dohme | Januvia | $189 | 13 payments
|
| Janssen Pharmaceuticals | Invokana | $189 | 12 payments
|
| Mannkind | Afrezza | $137 | 13 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $109 | 7 payments
|
| Sanofi-Aventis U.S. | Toujeo | $100 | 5 payments
|
| Insulet | Omnipod | $88 | 6 payments
|
| Amarin Pharma | Vascepa | $85 | 4 payments
|
| Amgen | Evenity | $61 | 3 payments
|
| Radius Health | Tymlos | $32 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | None | $22 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $20 | 1 payment
|
| AbbVie | Synthroid | $20 | 1 payment
|
| Shire North American Group | Natpara (Parathyroid Hormone) | $19 | 1 payment
|
| Pharmacyclics LLC An AbbVie | Imbruvica | $18 | 1 payment
|
| Sanofi Pasteur | Flublok Quadrivalent | $17 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $17 | 1 payment
|
| Corcept Therapeutics | Korlym | $14 | 1 payment
|
Professional record
- NPI
- 1700079035
- Licence
- CA A131831California A131831: Current · expires 2028-03-31
- Group
- Epic Care
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2345 Country Hills Dr, Antioch, CA, 94509
- NPI first listed
- 2007-08-21
- NPI last updated
- 2015-12-31
This is when the NPI record was last certified, not a medical board exam.